ConductScience.org, home

Trial · NCT05408793

Effects of Transcranial Pulse Stimulation on ASD

NCT05408793, Not applicable, Completed, The Hong Kong Polytechnic University

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Effects of Transcranial Pulse Stimulation on ASD. Trials, record NCT05408793. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05408793

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of Transcranial Pulse Stimulation on ASD
NCT number
NCT05408793
Status
Completed
Phases
Not applicable
Enrollment
32 participants, actual
Lead sponsor
The Hong Kong Polytechnic University
Conditions
Autism Spectrum Disorder, High-functioning Autism
Interventions
Transcranial Pulse Stimulation
First posted
2022-06-07
Last updated
2025-03-13

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAutism severityChanges in CARS scores from baseline at 3 months
The Childhood Autism Rating Scale (CARS) is a 15-item behavioral rating scale developed to identify autism and examine its severity. Total scores range from a low of 15 to a high of 60; scores below 30 indicate that the individual is in the non-autistic range, scores between 30 and 36.5 indicate mild to moderate autism, and scores from 37 to 60 indicate severe autism.
SecondaryAutistic traitsChanges in AQ scores from baseline at 3 months
Autism Spectrum Quotient (AQ) - adolescent version is a quick and quantitative self-report instrument for assessing how many autistic traits any adult has. The minimum score on the AQ is 0 and the maximum 50.
SecondarySocial deficitsChanges in SRS from baseline at 3 months
The Social Responsiveness Scale (SRS) is an instrument measuring the continuum of autism symptom severity which is commonly used in children and adolescents between the ages of 4 and 18 years. Parents rate on each item on a 4-item Likert scale (0-4). The higher the scores, the more severe the social deficits.
SecondaryAsperger's SyndromeChanges in ASAS from baseline at 3 months
Australian scale for Asperger's syndrome (ASAS) is a scale used to screen the behaviours and abilities indicative of Asperger's Syndrome in subjects older than 6 years old. It has 25 item and can be rated by parents/teachers/professionals who know the child.
SecondaryTheory of Mind and Social CognitionChanges in FPRT from baseline at 3 monthsFaux Pas Recognition Test (FPRT) is a very common advanced test to measure the theory of mind and social cognition
SecondaryExecutive FunctionChanges in Stroop test from baseline at 3 months
Stroop test is commonly used to assess the inhibition control component of executive function. It is testing the subject's ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute.
SecondaryWorking memoryChanges in WMTB from baseline at 3 months
Working Memory Test Battery (WMTB), which includes two verbal storage-only tasks (i.e. digital recall and word list recall), two complex memory span tasks (i.e. backward digit recall and counting recall), and two visuospatial storage tasks (block recall and variant- visual-pattern test).
SecondaryClinical Global ImpressionChanges in WMTB from baseline at 3 months
CGI-S is a 7-point clinician rating scale is based upon observed and reported symptoms, behaviour, and function in the past seven days. CGI-I is a 7-point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention.
SecondaryNeuroimagingMRI will be assessed at baseline at immediately and 2 weeks after post-stimulationParticipants will receive pre and post treatment MRI scan to measure any changes in structural and functional connectivity changes in the brain.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
36497688DERIVEDPubMed
40841688DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Social Slips Stories TaskSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05408793

GET https://conductscience.org/api/trials/v1/NCT05408793/registered